High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages

Journal of General Virology

Volumn 91, Issue 8, 2010, Pages 1909-1918

  Wu, Chengxiang ^a   Lu, Yuanan ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSAFETY; CELL CULTURE; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MACROPHAGE; MOLONEY LEUKEMIA ONCOVIRUS; MONOCYTE; MOUSE; NONHUMAN; POLYADENYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; ANIMAL; CELL LINE; DNA REPLICATION ORIGIN; GENE VECTOR; GENETICS; LYMPHOCYTE; VIROLOGY; VIRUS ASSEMBLY; VIRUS REPLICATION;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MUS; SIMIAN VIRUS 40;

ANIMALS; CELL LINE; CELLS, CULTURED; GENETIC VECTORS; HUMANS; LYMPHOCYTES; MACROPHAGES; MICE; MOLONEY MURINE LEUKEMIA VIRUS; PROMOTER REGIONS, GENETIC; REPLICATION ORIGIN; SIMIAN VIRUS 40; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 77955301939     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.020255-0     Document Type: Article

References (32)

1. Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M. & other authors (2009). Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360, 447-458.
2. Ayuk, F. A., Zander, A. R. & Fehse, B. (2001). T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors. Curr Gene Ther 1, 325-337.
3. Burke, B., Sumner, S., Maitland, N. & Lewis, C. E. (2002). Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol 72, 417-428.
4. Campbell, R. E., Tour, O., Palmer, A. E., Steinbach, P. A., Baird, G. S., Zacharias, D. A. & Tsien, R. Y. (2002). A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 99, 7877-7882.
5. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L. & other authors (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326, 818-823.
6. Clay, T. M., Custer, M. C., Spiess, P. J. & Nishimura, M. I. (1999). Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer. Pathol Oncol Res 5, 3-15.
7. Cockrell, A. S. & Kafri, T. (2003). HIV-1 vectors: fulfilment of expectations, further advances, and still a way to go. Curr HIV Res 1, 419-439.
8. Culver, K., Cornetta, K.,Morgan, R., Morecki, S., Aebersold, P., Kasid, A., Lotze, M., Rosenberg, S. A., Anderson, W. F. & Blaese, R. M. (1991). Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci U S A 88, 3155-3199. (Pubitemid 21916578)
9. + cells. Blood 88, 4166-4172.
10. Dou, H., Destache, C. J., Morehead, J. R., Mosley, R. L., Boska, M. D., Kingsley, J., Gorantla, S., Poluektova, L., Nelson, J. A. & other authors (2006). Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108, 2827-2835.
11. Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B. & Gendelman, H. E. (2009). Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183, 661-669.
12. Fischer, A. & Cavazzana-Calvo, M. (2008). Gene therapy of inherited diseases. Lancet 371, 2044-2047.
13. Gough, P. J. & Raines, E. W. (2003). Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector. Blood 101, 485-491.
14. Hawley, R. G. (2001). Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther 1, 1-17.
15. Landau, N. R. & Littman, D. R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol 66, 5110-5113.
16. May, T., Butueva, M., Bantner, S., Marcusic, D., Seppen, J., Weich, H., Hauser, H. & Wirth, D. (2009). Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16, 441-452.
17. McTaggart, S. & Al-Rubeai, M. (2002). Retroviral vectors for human gene delivery. Biotechnol Adv 20, 1-31. (Pubitemid 34458446)
18. Miller, J. W. (2008). Preliminary results of gene therapy for retinal degeneration. N Engl J Med 358, 2282-2284. (Pubitemid 351724462)
19. Naldini, L. (2009). A comeback for gene therapy. Science 326, 805-806.
20. Noser, J. A., Towers, G. J., Sakuma, R., Dumont, J.-M., Collins, M. K. L. & Ikeda, Y. (2006). Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. J Virol 80, 7769-7774. (Pubitemid 44092598)
21. Okasora, T., Jo, J. I. & Tabata, Y. (2008). Augmented anti-tumor therapy through natural targetability of macrophages genetically engineered by NK4 plasmid DNA. Gene Ther 15, 524-530. (Pubitemid 351405092)
22. Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90, 8392-8396.
23. Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. (2003). Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100, 183-188.
24. + melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res 65, 1570-1576.
25. Schambach, A., Mueller, D., Galla, M., Verstegen, M. M. A., Wagemaker, G., Loew, R., Baum, C. & Bohne, J. (2006). Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 13, 1524-1533. (Pubitemid 44567149)
26. Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M. & Stevenson, M. (2008). Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction. PLoS Pathog 4, e1000057. (Pubitemid 351811537)
27. Soneoka,Y., Cannon,P.M., Ramsdale,E.E., Griffiths, J.C.,Romano, G., Kingsman, S. M. & Kingsman, A. J. (1995). A transient three plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23, 628-633.
28. Wilson, H. M. & Kluth, D. C. (2003). Targeting genetically modified macrophages to the glomerulus. Nephron Exp Nephrol 94, e113-e118.
29. Wirth, J. J., Theisen, M. A. & Crowle, A. J. (1982). Culture conditions required for primary isolation and culture of mouse blood monocytes. J Reticuloendothel Soc 31, 325-327.
30. Wu, C. & Lu, Y. (2007). Inclusion of high molecular weight dextran in calcium phosphate-mediated transfection significantly improves gene transfer efficiency. Cell Mol Biol 53, 67-74. (Pubitemid 47451195)
31. Wu, C., Nerurkar, V. R., Yanagihara, R. & Lu, Y. (2008). Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors. J Virol Methods 153, 120-128.
32. Zeng, L., Yang, S., Wu, C., Ye, L. & Lu, Y. (2006). Effective transduction of primary mouse blood and bone marrow-derived monocytes/ macrophages by HIV-1-based defective lentiviral vectors. J Virol Methods 134, 66-73.